Xinlong Zang
- Molecular Biology
- Biomedical Engineering top 10%
- Immunology top 10%
- Biomaterials top 5%
- Oncology
- Co-authors
- Dawei ChenMingxi QiaoHaiyang HuXuehong ChenXiaoxu ZhangXiuli ZhaoMingyang ChengYihui Deng
- Topics
- Nanoplatforms for cancer theranostics (12 papers)Immune cells in cancer (8 papers)Nanoparticle-Based Drug Delivery (7 papers)
- Journals
- Chemical Engineering JournalJournal of Controlled ReleaseInternational Journal of Pharmaceutics
- Partner nations
- ChinaUnited StatesUruguay
In The Last Decade
Xinlong Zang
24 papers receiving 843 citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Molecular Biology 372
- Biomedical Engineering 280
- Immunology 242
- Biomaterials 211
- Oncology 128
Countries citing papers authored by Xinlong Zang
This map shows the geographic impact of Xinlong Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinlong Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinlong Zang more than expected).
Fields of papers citing papers by Xinlong Zang
This network shows the impact of papers produced by Xinlong Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinlong Zang. The network helps show where Xinlong Zang may publish in the future.
Co-authorship network of co-authors of Xinlong Zang
This figure shows the co-authorship network connecting the top 25 collaborators of Xinlong Zang. A scholar is included among the top collaborators of Xinlong Zang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinlong Zang. Xinlong Zang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Dual-sided centripetal microgrooved poly (D,L-lactide-co-caprolactone) disk encased in immune-regulating hydrogels for enhanced bone regenerationbreakdown → | 25 |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 43 | |
| 5 | 16 | |
| 6 | 19 | |
| 7 | 12 | |
| 8 | 39 | |
| 9 | 5 | |
| 10 | 39 | |
| 11 | 26 | |
| 12 | 84 | |
| 13 | 15 | |
| 14 | 19 | |
| 15 | 31 | |
| 16 | 76 | |
| 17 | 51 | |
| 18 | 146 | |
| 19 | 95 | |
| 20 | 31 |
About Xinlong Zang
Xinlong Zang is a scholar working on Immunology, Biomaterials and Molecular Medicine, having authored 25 papers that have together received 854 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (12 papers), Immune cells in cancer (8 papers) and Nanoparticle-Based Drug Delivery (7 papers). The work is most often cited by research in Biomaterials (211 citations), Immunology (242 citations) and Molecular Medicine (50 citations). Xinlong Zang has collaborated with scholars based in China, United States and Uruguay. Frequent co-authors include Dawei Chen, Mingxi Qiao, Haiyang Hu, Xuehong Chen, Xiaoxu Zhang, Xiuli Zhao, Mingyang Cheng, Yihui Deng, Mengjun Zhang and Zhen Li. Their work appears in journals such as Chemical Engineering Journal, Journal of Controlled Release and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.